TAZOCIN 2.25 G.

País: Israel

Idioma: anglès

Font: Ministry of Health

ingredients actius:

PIPERACILLIN AS SODIUM 2 G/VIAL; TAZOBACTAM SODIUM 0.25 G/VIAL

Disponible des:

NEOPHARM LTD

Codi ATC:

J01CR05

formulario farmacéutico:

POWDER FOR SOLUTION FOR INJECTION

Vía de administración:

I.V

Fabricat per:

WYETH PIPER. DIV.OF WYETH HOLDINGS CORP.

Grupo terapéutico:

PIPERACILLIN AND ENZYME INHIBITOR

indicaciones terapéuticas:

Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. Tazocin in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children above 2 years. Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Data d'autorització:

2010-06-01